会社概要
- 正式社名: Surya Life Sciences Ltd
- 登録国: India
- 住所: Plot no 3606 & 3616 GIDC estate,, Ankleshwar
- 従業員数: 500 - 999
説明:
Surya Life Sciences Ltd is an innovative company dedicated to developing and manufacturing pharmaceutical chemicals serving pharmaceutical companies worldwide, operating 4 WHO-GMP approved, ISO 9001:2015 certified manufacturing facilities that meet statutory environmental requirements. Since its founding, the company has established a strong presence in APIs for antifungal, antihistamine, cardiovascular, anti-inflammatory, anti-respiratory disorder, anesthetic, antihypertension, anti-ulcer and vitamin categories, with products well supported by DMFs, IMFs, dossiers and technical packages, guided by quality, innovation and technology as key attributes in its efforts toward global healthcare and sustainable growth.
事業活動
受託・アウトソーシングサービス
製造業者
医薬用化学品
製造業者
先発品原薬
製造業者
主要製品/サービス
- 原薬(API): Fexofenadine HCl
- 受託・アウトソーシングサービス: Montelukast, Guaifenesin, Rosuvastatin Calcium, Clopidogrel Bisulphate, P-aminobenzoic acid, Ketoconazole, Meloxicam, Fenofibrate, Ketoprofen, Metoprolol Tartrate, Metoprolol Succinate, Mesalazine, Benzocaine HCl, Sucralfate
- 医薬用化学品: Meta phenoxyl Benzyl Alcohol, Meta Anisidine, 1-(2-Hydroxyethyl)piperazine
当社の製品・サービス
Offer Service · Contract & Outsourcing Services
Sell · Active Pharmaceutical Ingredients (APIs)
Offer Service · Contract & Outsourcing Services
Offer Service · Contract & Outsourcing Services
Offer Service · Contract & Outsourcing Services
Offer Service · Contract & Outsourcing Services
Offer Service · Contract & Outsourcing Services
Offer Service · Contract & Outsourcing Services
Offer Service · Contract & Outsourcing Services
Offer Service · Contract & Outsourcing Services
Offer Service · Contract & Outsourcing Services
Offer Service · Contract & Outsourcing Services
Offer Service · Contract & Outsourcing Services
認証
GMP
ISO
証明
CPHI India 2026
11/2026 – 11/2026
CPHI India 2026
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す